HealthTree Logo
search more_vert
close
person Sign In / Create Account

Clinical Expertise

  • Multiple Myeloma

About

“My research interest is in drug development, so I conduct early-phase clinical trials — which means first-in-human studies — in order to look for therapies with novel mechanisms of action to treat patients and improve their outcomes. Many multiple myeloma patients have side effects and toxicities from previous treatments, and they have poor quality of life because of symptoms of the disease. These patients need therapies that can be tolerated easily.”

Location

The Ohio State University Comprehensive Cancer Center: 460 W 10th Ave, Columbus, OH 43210, USA

Get the latest thought leadership on Juvenile Myelomonocytic Leukemia delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Juvenile Myelomonocytic Leukemia Newsletter" for Juvenile Myelomonocytic Leukemia news, life with Juvenile Myelomonocytic Leukemia stories, Juvenile Myelomonocytic Leukemia clinical trials, Juvenile Myelomonocytic Leukemia 101 articles and events with Juvenile Myelomonocytic Leukemia experts.

Thanks to our HealthTree Community for Juvenile Myelomonocytic Leukemia Sponsors:

Johnson and Johnson
Sanofi
Pfizer
Regeneron
Adaptive
Bristol Myers Squibb